<DOC>
	<DOCNO>NCT00490880</DOCNO>
	<brief_summary>The purpose study evaluate efficacy gemcitabine cisplatin combine either radical cystectomy radiotherapy treatment bladder cancer .</brief_summary>
	<brief_title>Neoadjuvant Chemo ( Gemcitabine Cisplatin ) With Radical Cystectomy Radiotherapy Patients With Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologically cytologically proven urothelial carcinoma urinary bladder stage T2bT3 , N0/Nx , M0 . Patients must measurable disease . Response assessment evaluate accord RECIST criterion . Measurable lesion clearly define margin evaluate XRay , Transvesical Ultrasound , CTScan MRI , cystoscopy . Lesions serve measurable disease must longest diameter great equal 20 mm measure conventional technique great equal 10 mm spiral CT scan . Lesions measure physical examination must longest diameter great equal 20 mm . Patients prior concomitant malignant disease ( appropriately treat basal cell carcinoma skin carcinoma cervix ) PSA great 5.0 ng/mL Concurrent administration tumor therapy , include radiotherapy , cytotoxic chemotherapy , immunotherapy , molecular target therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>